Charles River Laboratories (CRL) Tops Q4 EPS by 12c ; Offers Guidance
Tweet
Share
E-mailGet Alerts CRL Hot Sheet
Price: $280.10 -0.42%
Financial Fact:
Continuing operations (in dollars per share): 0.78
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Continuing operations (in dollars per share): 0.78
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Charles River Laboratories (NYSE: CRL) reported Q4 EPS of $2.66, $0.12 better than the analyst estimate of $2.54. Revenue for the quarter came in at $1 billion versus the consensus estimate of $985.18 million.
GUIDANCE:
Charles River Laboratories sees FY2025 EPS of $9.10-$9.60, versus the consensus of $9.60.
For earnings history and earnings-related data on Charles River Laboratories (CRL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Cantor Fitzgerald Reiterates Overweight Rating on Merlin Labs (MRLN)
- SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
